Christian Drouet

ORCID: 0000-0003-1318-4278 · 4 papers in corpus
guideline 2025
Hereditary Angioedema with Normal C1 Inhibitor: an Updated International Consensus Paper on Diagnosis, Pathophysiology, and Treatment
Clinical reviews in allergy & immunology ·doi:10.1007/s12016-025-09027-4

Hereditary angioedema (HAE) has been recognized for almost 150 years. The newest form of HAE, where C1 inhibitor levels are normal (HAE-nC1INH), was first described in 2000. Over the last two decades, new types of apparent non-mast cell-med…

meta-analysis 2024
An integrated multi-tissue approach for endometriosis candidate biomarkers: a systematic review
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-023-01181-8

Biomarker identification could help in deciphering endometriosis pathophysiology in addition to their use in the development of non invasive diagnostic and prognostic approaches, that are essential to greatly improve patient care. Despite e…

other 2024
Hereditary angioedema with normal C1 inhibitor associated with carboxypeptidase N deficiency
The journal of allergy and clinical immunology. Global ·doi:10.1016/j.jacig.2024.100223

BACKGROUND: Hereditary angioedema (HAE) is a potentially life-threatening disorder characterized by recurrent episodes of subcutaneous or submucosal swelling. HAE with normal C1 inhibitor (HAE-nC1-INH) is an underdiagnosed condition. Althou…

other 2004
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond
The Journal of allergy and clinical immunology ·doi:10.1016/j.jaci.2004.06.047

Hereditary angioedema (HAE), a rare but life-threatening condition, manifests as acute attacks of facial, laryngeal, genital, or peripheral swelling or abdominal pain secondary to intra-abdominal edema. Resulting from mutations affecting C1…